RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients

Pediatric Surgery International

Volumn 29, Issue 11, 2013, Pages 1147-1152

  Honda, Shohei ^a   Miyagi, Hisayuki ^a   Suzuki, Hiromu ^b   Minato, Masashi ^a   Haruta, Masayuki ^c   Kaneko, Yasuhiko ^c   Hatanaka, Kanako C ^d   Hiyama, Eiso ^e   Kamijo, Takehiko ^f   Okada, Tadao ^a   Taketomi, Akinobu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c SAITAMA CANCER CENTER   (Japan)

^d HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^e Japanese Study Group for Pediatric Liver Tumor (JPLT)   (Japan)

^f CHIBA CANCER CENTER   (Japan)

Author keywords

Hepatoblastoma; Prognostic marker; RASSF1A methylation

Indexed keywords

BISULFITE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CELL TYPE; CHILD; DISEASE ASSOCIATION; DISTANT METASTASIS; DNA EXTRACTION; DNA METHYLATION; EVENT FREE SURVIVAL; FEMALE; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING;

DNA METHYLATION; DNA, NEOPLASM; FEMALE; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84886089763     PISSN: 01790358     EISSN: 14379813     Source Type: Journal    
DOI: 10.1007/s00383-013-3371-z     Document Type: Article

References (13)

1. von Schweinitz D (2012) Hepatoblastoma: recent developments in research and treatment. Semin Pediatr Surg 21:21-30
2. Zimmermann A, Lopez-Terrada D (2011) Pathology of pediatric liver tumors. In: Zimmermann A, Perilongo G, Malogolowkin M, von Schweinitz D (eds) Pediatric liver tumors. Springer, Heidelberg, pp 83-112
3. Agathanggelou A, Cooper NC, Latif F et al (2005) Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65:3497-3508
4. Honda S, Haruta M, Sugawara W et al (2008) The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients. Int J Cancer 123:1117-1125
5. Hishiki T, Matsunaga T, Sasaki F et al (2011) Outcome of hepatoblastomas treated using the Japanese study group for pediatric liver tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int 27:1-8
6. Brown J, Perilongo G, Shafford E et al (2000) Pretreatment prognostic factors for children with hepatoblastoma- results from the International society of paediatric oncology (SIOP) study SIOPEL 1. Eur J Cancer 36:1418-1425
7. Yang AS, Estécio MR, Doshi K et al (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32:e38
8. Ueda Y, Hiyama E, Kamimatsuse A et al (2011) Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability. J Pediatr Surg 46:2221-2227
9. Yamada S, Ohira M, Horie H et al (2004) Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene 23:5901-5911
10. Agathanggelou A, Cooper WN, Latif F (2005) Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65:3497-3508
11. Yang Q, Zage P, Kagan D et al (2004) Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma. Clin Cancer Res 10:8493-8500
12. Ohshima J, Haruta M, Fujiwara Y et al (2012) Methylation of the RASSF1A promoter is predictive of poor outcome among patients with Wilms tumor. Pediatr Blood Cancer 59:499-505
13. Cairo S, Armengol C, De Reyniès A et al (2008) Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14:471-484